NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

Grant Name
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Funder
HHS-NIH11(National Institutes of Health)
Research Field
Health
Deadline
April 5, 2024
Grant Size
$1,000,000
Contact Info
National Institutes of Health grantsinfo@nih.gov
Eligibility
Small businesses, Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Grant Number
PAR-21-224
Description
This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).

Funding resources

NIH General Instructions Download File
NIH Application Guide Open Link
Purdue Grant Writing Lab: Introduction to Grant Writing Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal Open Link

Quick share


Add deadline to calendar

April 5, 2024

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.


Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now